Skip to main content
CADL
NASDAQ Life Sciences

Q3 Loss Nearly Doubles to $21.9M as R&D Spend Jumps; Cash Lasts Into Q2 2028

Tom Rudovsky · Reported by Wiseek News
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$8.39
Mkt Cap
$641.991M
52W Low
$4.35
52W High
$14
52W Position info
93% above low
Off High info
40% below high
Rel. Volume info
0.8× avg
Market data snapshot near publication time

CADL sits 93% above its 52-week low of $4.35.

Summary

Candel's Q3 net loss widened to $21.9M from $11.3M a year earlier, driven by R&D expense of $15.6M versus $8.5M and G&A of $7.4M versus $4.7M. The company ended September with $203.1M in cash, up from $119.7M at December 31, 2025, and now says that funds operations into Q2 2028 — extending the runway past the Q1 2028 guide given with Q2 results in August. No new trial data came with the release; the value case still rests on the planned mid-2027 BLA submission for aglatimagene, which the same-day 8-K flagged. The quarter shows spending ramping toward commercial readiness while the balance sheet covers it, so dilution risk near term is low but the loss rate is climbing.

At the time of this announcement, CADL was trading at $8.39 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $642M. The 52-week trading range was $4.35 to $14.00. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Wiseek News.


Price Chart

Share this article

Copied!

CADL - Latest Insights

CADL
Nov 13, 2026, 3:00 AM EST
Source: Wiseek News
Importance Score:
8
Price at Filing: $5.11
Real-time Price: $6.00 info
Change: +$0.8897 (+17%) info
Market Cap: $474.415M info
CADL
Nov 12, 2026, 4:05 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $8.39
Real-time Price: $6.00 info
Change: -$2.39 (-28%) info
Market Cap: $474.415M info
CADL
Oct 01, 2026, 8:05 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $10.40
Real-time Price: $6.00 info
Change: -$4.40 (-42%) info
Market Cap: $474.415M info
CADL
Sep 30, 2026, 8:05 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $10.96
Real-time Price: $6.00 info
Change: -$4.96 (-45%) info
Market Cap: $474.415M info
CADL
Sep 09, 2026, 4:50 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $12.14
Real-time Price: $6.00 info
Change: -$6.14 (-51%) info
Market Cap: $474.415M info